久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Pharmaceutical companies grab Chinese market opportunities

By LIU ZHIHUA | China Daily | Updated: 2023-02-03 09:11
Share
Share - WeChat
Visitors gather at Danish pharmaceutical company Novo Nordisk's booth during the fifth China International Import Expo in Shanghai in November. [PHOTO by ZHU XINGXIN/CHINA DAILY]

MNCs share confidence to invest, expand with nation's high-standard opening-up

As the first multinational healthcare company to settle in the Lingang Special Area of the China (Shanghai) Pilot Free Trade Zone, Danish pharmaceutical company Novo Nordisk announced at the end of last year that it would invest 400 million yuan ($59.6 million) in a newly established company in the area.

With that investment, the company will upgrade its whole industrial layout in China to better seize the opportunities of China's high-quality development, said Zhou Xiaping, global senior vice-president of Novo Nordisk and president of Novo Nordisk China.

That's just one example from the past year of foreign pharmaceutical enterprises casting a vote of confidence in China's market to expand their investments, eyeing brightening prospects.

China, the world's second-largest economy and pharmaceutical market, only after the United States, has been playing an increasingly growing role in the global pharmaceutical market, both as a consumer country and as a crucial link in the global pharmaceutical industrial and supply chains.

The annual tone-setting Central Economic Work Conference, held in December, said China will make greater efforts to attract and utilize foreign capital, widen market access, promote the opening-up of modern service industries and grant foreign-funded enterprises national treatment.

The innovation and creativity potential of the whole society should be unleashed to the greatest extent, while the potential of the domestic market will also be fully tapped so that domestic demand can play a stronger role in driving economic growth, according to the meeting.

Experts and business leaders said China's unwavering commitment to deepening reform and expanding high-level opening-up, its stress on innovation and technological advancement, and the fast-growing pharmaceutical market in China due to the large population's increasing awareness and spending on healthcare products and services, will jointly shore up foreign investment into its pharmaceutical industry despite challenges and complexities from the external environment.

They also said sectors such as biomedicine, vaccines, antivirus solutions, and in particular, rare diseases and chronic disease treatments, have especially huge growth potential.

Seeing the China market potential and impressed by China's resolve to expand high-level opening-up, Japanese pharmaceutical company Astellas has set a strategic focus on breakthroughs in oncology and innovative drugs and therapies in China.

Currently, it is accelerating the introduction of innovative drugs to China and enhancing accessibility, which include a first-in-class antibody conjugate drug.

"China has always been a vital market for Astellas' global growth and it has now risen to the top tier of Astellas' global strategic markets based on its strong performance and significance," said Hiroshi Hamaguchi, chairman and president of Astellas China.

"As the world's second-largest pharmaceutical market, China presents us with great development potential with tremendous unmet medical needs ... we will continue to leverage China's favorable policies, and work with the government and all business partners to actively explore every possibility of (drug registration) acceleration," he said.

Huang Feng, chairman of the Shanghai Foreign Investment Association, said foreign investors and multinational companies have advanced research and development technology and experience to meet China's huge market demand, which will ensure promising growth prospects of foreign investment into China's pharmaceutical industry.

In particular, the country's newest catalog of industries for attracting foreign investment, which took effect on Jan 1, continues to encourage foreign investment in the manufacturing industry and has shed a spotlight on sectors including rare disease drugs, children's medicines and high-end medical devices, he said.

1 2 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 欧美日韩成人在线视频 | 成人中文字幕一区二区三区 | 色www永久免费 | 看黄网址 | 欧美69视频 | 国产成人免费高清视频 | 波多野结衣在线观看3人 | 亚洲伊人色综合网站亚洲伊人 | 三级毛片免费观看 | 成人免费毛片视频 | 亚洲国产欧美在线人成精品一区二区 | 欧美在线一区二区三区精品 | 国产日韩久久久精品影院首页 | 国产精品久久自在自线观看 | 欧美大片a一级毛片视频 | 直接看的毛片 | 综合欧美视频一区二区三区 | 中文乱码字幕午夜无线观看 | 韩国精品一区视频在线播放 | cekc欧美 | 一级a毛片 | 久久国产精品亚洲 | 成在线人视频免费视频 | 特级毛片全部免费播放a一级 | 六月丁香久久丫 | 国产欧美日韩在线不卡第一页 | 一区不卡在线观看 | 国产片18在线观看 | 91免费网站在线看入口黄 | 欧美成人精品在线 | 欧美一级特黄特色大片 | 欧美成人怡红院在线观看 | 国产精品大片天天看片 | 91久久福利国产成人精品 | 全部免费国产潢色一级 | 国产a级三级三级三级中国 国产a级特黄的片子视频 | 欧美性色大片 | www国产| 91久久精品青青草原伊人 | 米奇888在线播放欧美 | 国产精品19p|